Serotiny is a company that is engaged in the discovery of proteins for cell therapies. It focuses on such proteins as CARs (chimeric antigen receptors) for the treatment of cancers and genetic disorders.
Type | Private | |
Founded | 2014 | |
Website | serotiny.bio |
Employees (est.) (Feb 2021) | 11 | (+10%) |
Cybersecurity rating | B | More |
Founding Date | 2014 |
Serotiny total Funding | $3 m |
Serotiny latest funding size | $3 m |
Time since last funding | 3 years ago |
Serotiny investors | NanoDimension, 8VC |
Serotiny has 58 Twitter Followers. The number of followers has increased 0.7% month over month and increased 0.7% quarter over quarter
When was Serotiny founded?
Serotiny was founded in 2014.
How many employees does Serotiny have?
Serotiny has 11 employees.
Who are Serotiny competitors?
Competitors of Serotiny include Rznomics, Paragon Gene Therapy and Senhwa Biosciences.
Receive alerts for 300+ data fields across thousands of companies